Psychology & Psychiatry

Undervaccination for COVID-19 found for individuals with schizophrenia

(HealthDay)—Individuals with schizophrenia are undervaccinated against COVID-19 compared with age- and gender-matched controls in Israel, according to a research letter published online May 18 in World Psychiatry.

Dana Tzur Bitan, Ph.D., from Ariel University in Israel, examined COVID-19 vaccination among a total of 50,240 cases: 25,120 patients with schizophrenia and 25,120 age- and gender-matched controls. Data were obtained from the databases of the Clalit Health Service in Israel.

Bitan found that compared with the control group, the odds of receiving vaccination were significantly lower in the schizophrenia group (odds ratio, 0.80). In the subsample aged 16 to 21 years, there were no significant differences observed. As age increased, the differences between the two groups were more profound: odds ratios, 0.90, 0.83, and 0.61 for the subsamples aged 21 to 40, 40 to 60, and 60 years and older, respectively. For both men and women, the odds of being vaccinated were lower in the schizophrenia group, with a slightly greater gap in vaccination rates seen for men versus women (odds ratios, 0.79 versus 0.82, respectively).

“The lower rates of vaccination among patients with schizophrenia reported in this study should alert public health policy entities to provide better care in the form of easier access to COVID-19 mitigation/prevention efforts for individuals with schizophrenia,” Bitan writes.

Vaccination linked to drop in COVID-19 hospitalization in those 65 and over

More information:
Abstract/Full Text

Copyright © 2021 HealthDay. All rights reserved.

Undervaccination for COVID-19 found for individuals with schizophrenia (2021, May 26)
retrieved 26 May 2021

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Ad Block Detected

Welcome to Mediexpose, Please support our journalism by allowing ads. With support from readers like you, we can continue to deliver the best. You can support us free by simply allowing ads.